Skip to main content
Top

Drugs

Issue 8/2021

Content (9 Articles)

Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes?

Wendy H. Updike, Olivia Pane, Rachel Franks, Faizah Saber, Farah Abdeen, Derek D. Balazy, Nicholas W. Carris

IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses

Youkyung S. Roh, Justin Choi, Nishadh Sutaria, Micah Belzberg, Madan M. Kwatra, Shawn G. Kwatra

Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review

Marta S. Palmeirim, Sabine Specht, Ivan Scandale, Irene Gander-Meisterernst, Monika Chabicovsky, Jennifer Keiser

Targeting AMPK by Statins: A Potential Therapeutic Approach

Sajad Dehnavi, Amirhossein Kiani, Mahvash Sadeghi, Ali Farhadi Biregani, Maciej Banach, Stephen L. Atkin, Tannaz Jamialahmadi, Amirhossein Sahebkar

Fosdenopterin: First Approval

  • AdisInsight Report

Connie Kang

Ponesimod: First Approval

Anthony Markham

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images